Phosphate Reduction Or Supplementation Intervention Trial
- Conditions
- Chronic Kidney Disease (chronische nierinsufficiëntie)
- Registration Number
- NL-OMON27814
- Lead Sponsor
- niversity Medical Center Groningen
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 42
Inclusion Criteria
• CKD
•Estimated GFR >30 mL /min/1.73 m2
Exclusion Criteria
•Current use of phosphate binder therapy
•Hyperphosphatemia >2.00 mmol/L
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Residual albuminuria (24h urine collection)
- Secondary Outcome Measures
Name Time Method C-terminal FGF23 levels, 24-hourly phosphorus excretion, serum phosphate levels, serum calcium levels, 24-hourly calcium excretion, residual proteinuria, systolic blood pressure, Serum calcification propensity<br>